267 related articles for article (PubMed ID: 25855048)
21. TERT promoter mutations are frequent and show association with MED12 mutations in phyllodes tumors of the breast.
Yoshida M; Ogawa R; Yoshida H; Maeshima A; Kanai Y; Kinoshita T; Hiraoka N; Sekine S
Br J Cancer; 2015 Oct; 113(8):1244-8. PubMed ID: 26355235
[TBL] [Abstract][Full Text] [Related]
22. Myxoid fibroadenomas differ from conventional fibroadenomas: a hypothesis-generating study.
Lozada JR; Burke KA; Maguire A; Pareja F; Lim RS; Kim J; Gularte-Merida R; Murray MP; Brogi E; Weigelt B; Reis-Filho JS; Geyer FC
Histopathology; 2017 Oct; 71(4):626-634. PubMed ID: 28513873
[TBL] [Abstract][Full Text] [Related]
23. Loss of imprinting of IGF2 in fibroadenomas and phyllodes tumors of the breast.
Mishima C; Kagara N; Tanei T; Naoi Y; Shimoda M; Shimomura A; Shimazu K; Kim SJ; Noguchi S
Oncol Rep; 2016 Mar; 35(3):1511-8. PubMed ID: 26676988
[TBL] [Abstract][Full Text] [Related]
24. A novel genomic panel as an adjunctive diagnostic tool for the characterization and profiling of breast Fibroepithelial lesions.
Sim Y; Ng GXP; Ng CCY; Rajasegaran V; Wong SF; Liu W; Guan P; Nagarajan S; Ng WY; Thike AA; Lim JCT; Nasir NDBM; Tan VKM; Madhukumar P; Yong WS; Wong CY; Tan BKT; Ong KW; Teh BT; Tan PH
BMC Med Genomics; 2019 Oct; 12(1):142. PubMed ID: 31647027
[TBL] [Abstract][Full Text] [Related]
25. Massively parallel sequencing analysis of synchronous fibroepithelial lesions supports the concept of progression from fibroadenoma to phyllodes tumor.
Piscuoglio S; Geyer FC; Burke KA; Murray MP; Ng CK; Mota A; Marchio C; Berman SH; Norton L; Brogi E; Weigelt B; Reis-Filho JS
NPJ Breast Cancer; 2016; 2():16035. PubMed ID: 28721388
[TBL] [Abstract][Full Text] [Related]
26. Stromal
da Silva EM; Beca F; Sebastiao APM; Murray MP; Silveira C; Da Cruz Paula A; Pareja F; Wen HY; D'Alfonso TM; Edelweiss M; Weigelt B; Brogi E; Reis-Filho JS; Zhang H
J Clin Pathol; 2022 Feb; 75(2):133-136. PubMed ID: 33376197
[TBL] [Abstract][Full Text] [Related]
27. Exome sequencing identifies highly recurrent MED12 somatic mutations in breast fibroadenoma.
Lim WK; Ong CK; Tan J; Thike AA; Ng CC; Rajasegaran V; Myint SS; Nagarajan S; Nasir ND; McPherson JR; Cutcutache I; Poore G; Tay ST; Ooi WS; Tan VK; Hartman M; Ong KW; Tan BK; Rozen SG; Tan PH; Tan P; Teh BT
Nat Genet; 2014 Aug; 46(8):877-80. PubMed ID: 25038752
[TBL] [Abstract][Full Text] [Related]
28. Are both distinct epithelial and stromal cells molecular analysis from phyllodes tumors versus fibroadenoma components affected in breast fibroepithelial progression?
Waitzberg ÂFL; Ferreira ENE; Pinilla M; Pineda P; Malinverni ACM; Soares FA; Carraro DM
Acta Cir Bras; 2023; 38():e386823. PubMed ID: 38055384
[TBL] [Abstract][Full Text] [Related]
29.
Chang HY; Koh VCY; Md Nasir ND; Ng CCY; Guan P; Thike AA; Teh BT; Tan PH
J Clin Pathol; 2020 Jan; 73(1):51-56. PubMed ID: 31662438
[TBL] [Abstract][Full Text] [Related]
30. MED12 exon 2 mutation as a highly sensitive and specific marker in distinguishing phyllodes tumours from other spindle neoplasms of the breast.
Lien HC; Huang CS; Yang YW; Jeng YM
APMIS; 2016 May; 124(5):356-64. PubMed ID: 26860948
[TBL] [Abstract][Full Text] [Related]
31. mRNA expression profiling of phyllodes tumours of the breast: identification of genes important in the development of borderline and malignant phyllodes tumours.
Jones AM; Mitter R; Poulsom R; Gillett C; Hanby AM; Tomlinson IP; Sawyer EJ;
J Pathol; 2008 Dec; 216(4):408-17. PubMed ID: 18937276
[TBL] [Abstract][Full Text] [Related]
32. Morphologic and genetic heterogeneity in breast fibroepithelial lesions-a comprehensive mapping study.
Tan BY; Md Nasir ND; Chang HY; Ng CCY; Guan P; Nagarajan S; Rajasegaran V; Lee JY; Lim JQ; Thike AA; Teh BT; Tan PH
Mod Pathol; 2020 Sep; 33(9):1732-1745. PubMed ID: 32322022
[TBL] [Abstract][Full Text] [Related]
33. Fibroepithelial lesions; The WHO spectrum.
Krings G; Bean GR; Chen YY
Semin Diagn Pathol; 2017 Sep; 34(5):438-452. PubMed ID: 28688536
[TBL] [Abstract][Full Text] [Related]
34. Genomic profile of breast sarcomas: a comparison with malignant phyllodes tumours.
Lim SZ; Ng CCY; Rajasegaran V; Guan P; Selvarajan S; Thike AA; Nasir NDBM; Koh VCY; Tan BKT; Ong KW; Teh BT; Tan PH
Breast Cancer Res Treat; 2019 Apr; 174(2):365-373. PubMed ID: 30511242
[TBL] [Abstract][Full Text] [Related]
35. A comprehensive genetic profile of phyllodes tumours of the breast detects important mutations, intra-tumoral genetic heterogeneity and new genetic changes on recurrence.
Jones AM; Mitter R; Springall R; Graham T; Winter E; Gillett C; Hanby AM; Tomlinson IP; Sawyer EJ;
J Pathol; 2008 Apr; 214(5):533-44. PubMed ID: 18288784
[TBL] [Abstract][Full Text] [Related]
36. Genetics and genomics of breast fibroadenomas.
Loke BN; Md Nasir ND; Thike AA; Lee JYH; Lee CS; Teh BT; Tan PH
J Clin Pathol; 2018 May; 71(5):381-387. PubMed ID: 29248888
[TBL] [Abstract][Full Text] [Related]
37. Molecular insights into paediatric breast fibroepithelial tumours.
Tay TKY; Guan P; Loke BN; Nasir NDM; Rajasegaran V; Thike AA; Lian D; Chang KTE; Teh BT; Ng CCY; Tan PH
Histopathology; 2018 Nov; 73(5):809-818. PubMed ID: 29969836
[TBL] [Abstract][Full Text] [Related]
38. Fibroepithelial tumours of the breast-a review.
Lerwill MF; Lee AHS; Tan PH
Virchows Arch; 2022 Jan; 480(1):45-63. PubMed ID: 34505197
[TBL] [Abstract][Full Text] [Related]
39. DNA methylation profiling of phyllodes and fibroadenoma tumours of the breast.
Huang KT; Dobrovic A; Yan M; Karim RZ; Lee CS; Lakhani SR; Fox SB
Breast Cancer Res Treat; 2010 Nov; 124(2):555-65. PubMed ID: 20563638
[TBL] [Abstract][Full Text] [Related]
40. Comprehensive screening for MED12 mutations in gynaecological mesenchymal tumours identified morphologically distinctive mixed epithelial and stromal tumours.
Yuan CT; Huang WC; Lee CH; Lin MC; Lee CH; Kao YC; Huang HY; Kuo KT; Lee JC
Histopathology; 2017 May; 70(6):954-965. PubMed ID: 28002623
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
